$1.55
0.149.93%
At close: -
$1.51
-0.04-2.58%
After Hours: Dec 20, 6:19 PM EDT
Salarius Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Salarius Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $-0.76 | $-2.40 | 68.3 % |
Jun 2024 | 2024-08-09 | $-2.37 | $-53.60 | 95.6 % |
Mar 2024 | 2024-05-13 | $-3.28 | $-53.60 | 93.9 % |
Dec 2023 | 2024-03-22 | $-1.76 | $-8.08 | 78.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2021 | 2022-03-10 | $0 | $430.00K | -100.0 % |
Sep 2021 | 2021-11-04 | $0 | $1.16M | -100.0 % |
Jun 2021 | 2021-08-05 | $571.39K | $1.28M | -55.4 % |
Mar 2021 | 2021-05-12 | $1.27M | $1.37M | -7.37 % |
Salarius Pharmaceuticals (SLRX) is scheduled to report earnings on March 21, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.76, which beat the estimate of $-2.40.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.